mAbsolve to present STR technology at PEGS Boston 2022

Our CSO, Ian Wilkinson, will be attending PEGS Boston in the week of 2-6th May. Our antibody silencing ...
Read More

mAbsolve to present webinar hosted by The Antibody Society

Our CSO, Ian Wilkinson, will be presenting on the importance of attenuating effector functions in therapeutics antibodies as ...
Read More

Absolute Antibody Licenses Novel Fc Silencing Technology from mAbsolve

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, and mAbsolve, developers of a novel ...
Read More

evitria AG announces license of mAbsolve STR technology

evitria AG, the market-leading transient CHO expression service provider, today announces the closing of a license agreement with ...
Read More

mAbsolve Quarterly Company Update

This quarter saw our publication on the STR silencing technology accepted and published in PLOS ONE (see here). ...
Read More

STR silencing published in PLoS ONE

We are delighted to announce that our novel STR silencing technology has been recently published in the peer ...
Read More

mAbsolve Quarterly Company Update

Along with our updated website we are also launching the first edition of our company updates. We intend ...
Read More

mAbsolve Launches Updated Website

When the company was founded in December 2019 we were a startup with an interesting technology in the ...
Read More

mAbsolve’s STR Patent Application Published

mAbsolve’s international patent application on a novel Fc silencing technology has today been published under application number WO/2021/234402.
Read More

Dr. Ian Wilkinson joins mAbsolve as Chief Scientific Officer

Starting today Dr. Ian Wilkinson joins mAbsolve as Chief Scientific Officer, having been a Founder and non-executive Director ...
Read More

Prof. Geoff Hale to present at Antibody Drug Development Summit 2021

Prof. Geoff Hale, CEO of mAbsolve, will present on our novel STR Fc silencing technology at the upcoming ...
Read More

mAbsolve Files International Patent Application

mAbsolve has today filed an international patent application PCT/GB2021/051233 on its novel Fc silencing technology.
Read More